Journal ArticleDOI
Global Cancer Incidence and Mortality Rates and Trends—An Update
Reads0
Chats0
TLDR
Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates.Abstract:
There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for 2003-2007. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs.read more
Citations
More filters
Journal ArticleDOI
Aptamers as Diagnostic Tools in Cancer.
Dario Ruiz Ciancio,Mauricio R Vargas,William H. Thiel,Martin A. Bruno,Paloma H. Giangrande,Maria Belen Mestre +5 more
TL;DR: The principal considerations and recent updates in cancer detection and imaging through aptamer-based molecules are reviewed.
Journal ArticleDOI
Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets
Matt R. Paul,Tien-chi Pan,Dhruv K. Pant,Natalie N. C. Shih,Yan Chen,Kyra L. Harvey,Aaron Solomon,David B. Lieberman,Jennifer J.D. Morrissette,Danielle Soucier-Ernst,Noah Goodman,S. William Stavropoulos,Kara N. Maxwell,Candace Clark,George K. Belka,Michael Feldman,Angela DeMichele,Lewis A. Chodosh +17 more
TL;DR: Immunohistochemical analyses revealed that metastases preferentially inactivate pRB, upregulate the mTORC1 and WNT signaling pathways, and exhibit nuclear localization of activated PKA, which identifies multiple therapeutic targets in metastatic recurrence that are not significantly mutated in primary cancers.
Journal ArticleDOI
DEB-TACE: a standard review.
Fabio Melchiorre,Francesca Patella,Lorenzo Carlo Pescatori,Filippo Pesapane,Enrico Maria Fumarola,Pierpaolo Biondetti,Pietro Maria Brambillasca,Cristian Giuseppe Monaco,Anna Maria Ierardi,Giuseppe Franceschelli,Gianpaolo Carrafiello +10 more
TL;DR: It is underline that there is no evidence about the superiority of DEB-TACE over conventional TACE in terms of efficacy, but there may be some benefits with respect to safety especially with the improvement of new technologies.
Journal ArticleDOI
A Light-Triggered Mesenchymal Stem Cell Delivery System for Photoacoustic Imaging and Chemo-Photothermal Therapy of Triple Negative Breast Cancer.
Chang Xu,Qishuai Feng,Haocheng Yang,Guangxue Wang,Liqun Huang,Qianwen Bai,Chuyi Zhang,Yilong Wang,Yingna Chen,Qian Cheng,Mengwei Chen,Yu Han,Zuoren Yu,Maciej S. Lesniak,Yu Cheng +14 more
TL;DR: In vivo studies show that the MSCs‐LDGI has the enhanced migration and penetration abilities in the tumor area via both intratumoral and intravenous injection approaches compared with LDGI, and shows the best antitumor efficacy via chemo‐photothermal therapy compared to other treatment groups in the TNBC model of nude mice.
Journal ArticleDOI
MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and cancer: an old debate revisited
Cesar Luiz Boguszewski,John Ayuk +1 more
TL;DR: The existing data relating to cancer risk and mortality in acromegaly is reviewed, exploring the limitations of study designs and the impact of changes in disease control and patient outcomes over time.
References
More filters
Journal ArticleDOI
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
Journal ArticleDOI
The global health burden of infection-associated cancers in the year 2002.
TL;DR: The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas.
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]
J Ferlay,I Soerjomataram,M Ervik,R Dikshit,S Eser,Colin Mathers,M Rebelo,D.M. Parkin,David Forman,Freddie Bray,S Elser,M Ervick,Donald Maxwell Parkin +12 more
Journal ArticleDOI
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
TL;DR: The authors update the incidence trends through 1994 and further consider the trends by age group.